Stephen D. Barrett

2.4k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Stephen D. Barrett is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Stephen D. Barrett has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Stephen D. Barrett's work include Melanoma and MAPK Pathways (5 papers), Receptor Mechanisms and Signaling (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Stephen D. Barrett is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Receptor Mechanisms and Signaling (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Stephen D. Barrett collaborates with scholars based in United States, United Kingdom and Ireland. Stephen D. Barrett's co-authors include Haile Tecle, David T. Dudley, Wilbur R. Leopold, Alexander J. Bridges, Sally Przybranowski, Judith S. Sebolt–Leopold, Alan R. Saltiel, Keri Van Becelaere, Richard Gowan and Román Herrera and has published in prestigious journals such as Nature Medicine, Cancer Research and Langmuir.

In The Last Decade

Stephen D. Barrett

17 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

1999 804 citations Judith S. Sebolt–Leopold, David T. Dudley et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen D. Barrett United States	11	907	375	243	167	115	18	1.4k
Alain De Pover Switzerland	16	1.2k 1.4×	341 0.9×	139 0.6×	192 1.1×	142 1.2×	25	1.6k
Hidehisa Iwata Japan	22	683 0.8×	277 0.7×	351 1.4×	79 0.5×	87 0.8×	44	1.4k
Francesca Musumeci Italy	23	861 0.9×	247 0.7×	577 2.4×	136 0.8×	110 1.0×	65	1.6k
Martin Schröder Germany	21	678 0.7×	284 0.8×	142 0.6×	191 1.1×	66 0.6×	45	1.3k
Tingting Zhao China	25	759 0.8×	314 0.8×	271 1.1×	81 0.5×	288 2.5×	74	1.5k
Bianca Sperl Germany	11	819 0.9×	722 1.9×	138 0.6×	175 1.0×	145 1.3×	19	1.5k
Monica Lupi Italy	24	913 1.0×	332 0.9×	151 0.6×	84 0.5×	220 1.9×	67	1.5k
Dario Ballinari Italy	19	608 0.7×	400 1.1×	178 0.7×	60 0.4×	72 0.6×	54	1.1k
Grégoire Prévost France	24	1.0k 1.1×	645 1.7×	181 0.7×	60 0.4×	239 2.1×	56	1.7k
Abhijit Bhat United States	15	721 0.8×	331 0.9×	292 1.2×	75 0.4×	198 1.7×	28	1.2k

Countries citing papers authored by Stephen D. Barrett

Since Specialization

Citations

This map shows the geographic impact of Stephen D. Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Barrett more than expected).

Fields of papers citing papers by Stephen D. Barrett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Barrett. The network helps show where Stephen D. Barrett may publish in the future.

Co-authorship network of co-authors of Stephen D. Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen D. Barrett. A scholar is included among the top collaborators of Stephen D. Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen D. Barrett. Stephen D. Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Holt, Melissa C., Fred L. Ciske, James B. Kramer, et al.. (2020). Novel amide and imidazole compounds as potent hematopoietic prostaglandin D2 synthase inhibitors. Bioorganic & Medicinal Chemistry Letters. 34. 127759–127759. 5 indexed citations

Owen, Thomas A., et al.. (2020). KMN-159, a novel EP4 receptor selective agonist, stimulates osteoblastic differentiation in cultured whole rat bone marrow. Gene. 748. 144668–144668. 4 indexed citations

Dong, Shijun, Kuiwen Zhang, P. K. Senecal, et al.. (2020). A comparative reactivity study of 1-alkene fuels from ethylene to 1-heptene. Proceedings of the Combustion Institute. 38(1). 611–619. 44 indexed citations

Holt, Melissa C., Chi S. Ho, María I. Morano, Stephen D. Barrett, & Adam J. Stein. (2019). Improved homology modeling of the human & rat EP4 prostanoid receptors. BMC Molecular and Cell Biology. 20(1). 37–37.

Barrett, Stephen D., Melissa C. Holt, James B. Kramer, et al.. (2019). Difluoromethylene at the γ-Lactam α-Position Improves 11-Deoxy-8-aza-PGE₁ Series EP₄ Receptor Binding and Activity: 11-Deoxy-10,10-difluoro-8-aza-PGE₁ Analog (KMN-159) as a Potent EP₄ Agonist. Journal of Medicinal Chemistry. 62(9). 4731–4741. 29 indexed citations

Barrett, Stephen D., Alexander J. Bridges, David T. Dudley, et al.. (2008). The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. Bioorganic & Medicinal Chemistry Letters. 18(24). 6501–6504. 222 indexed citations

Warmus, Joseph S., Cathlin Flamme, Stephen D. Barrett, et al.. (2008). 2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles—O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase). Bioorganic & Medicinal Chemistry Letters. 18(23). 6171–6174. 60 indexed citations

Schaefer, Caralee, Mark E. Lesch, James L. Mobley, et al.. (2007). Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: Potential proinflammatory mechanisms. Arthritis & Rheumatism. 56(10). 3347–3357. 84 indexed citations

Dutta, Samrat, et al.. (2006). Cross Metathesis on Olefin-Terminated Monolayers on Si(111) Using the Grubbs' Catalyst. Langmuir. 22(5). 2146–2155. 31 indexed citations

10.

Kaufman, Michael D., Stephen D. Barrett, Cathlin Flamme, et al.. (2004). Synthesis and SAR development of PD 0325901, a potent and highly bioavailable MEK inhibitor.. Cancer Research. 64. 573–573. 1 indexed citations

11.

Tecle, Haile, Roy D. Schwarz, Stephen D. Barrett, et al.. (2000). CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology. Pharmaceutica Acta Helvetiae. 74(2-3). 141–148. 11 indexed citations

12.

Barrett, Stephen D., et al.. (2000). New Route to 4-Aminocyclopent-2-en-1-ols: Synthesis and Enantioselective Rearrangement of 4-Amino-substituted Cyclopentene Oxides. Tetrahedron. 56(49). 9633–9640. 32 indexed citations

13.

Sebolt–Leopold, Judith S., David T. Dudley, Román Herrera, et al.. (1999). Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nature Medicine. 5(7). 810–816. 804 indexed citations breakdown →

14.

Barrett, Stephen D., Juan C. Jaén, Bradley W. Caprathe, Anthony J. Thomas, & Haile Tecle. (1997). EFFICIENT SYNTHESIS OFEXO-1-AZABICYCLO[2.2.1]HEPTAN-3-OL. Organic Preparations and Procedures International. 29(3). 330–335. 3 indexed citations

15.

Jaén, Juan C., Stephen D. Barrett, Mark R. Brann, et al.. (1995). In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832. Life Sciences. 56(11-12). 845–852. 18 indexed citations

16.

Tecle, Haile, Juan C. Jaén, Corinne E. Augelli‐Szafran, et al.. (1995). Z-(±)-1-azabicyclo[2.2.1]heptan-3-one, O-(3-aryl-2-propynyl) oximes as potential m1-subtype selective muscarinic agonists. Bioorganic & Medicinal Chemistry Letters. 5(6). 631–636. 5 indexed citations

17.

Barrett, Stephen D., et al.. (1990). SN2′ Substitutions of 1,3-Dichloropropenes with the Functionalized Copper-Zinc Reagents RCu(CN)ZnX. Tetrahedron Letters. 31(13). 1829–1832. 13 indexed citations

18.

Thompson, James N. & Stephen D. Barrett. (1969). Growth of the Mongolian Gerbil, Meriones unguiculatus. Transactions of the Kansas Academy of Science. 72(2). 223–223. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact